These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 25960053)
1. Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy. Xuan M; Shao J; Dai L; He Q; Li J Adv Healthc Mater; 2015 Aug; 4(11):1645-52. PubMed ID: 25960053 [TBL] [Abstract][Full Text] [Related]
2. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819 [TBL] [Abstract][Full Text] [Related]
3. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery. Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516 [TBL] [Abstract][Full Text] [Related]
4. Hydrophobic end-gated silica nanotubes for intracellular glutathione-stimulated drug delivery in drug-resistant cancer cells. Wang L; Kim M; Fang Q; Min J; Jeon WI; Lee SY; Son SJ; Joo SW; Lee SB Chem Commun (Camb); 2013 Apr; 49(31):3194-6. PubMed ID: 23417143 [TBL] [Abstract][Full Text] [Related]
5. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634 [TBL] [Abstract][Full Text] [Related]
6. Dendrimerlike mesoporous silica nanoparticles as pH-responsive nanocontainers for targeted drug delivery and bioimaging. Dai L; Zhang Q; Li J; Shen X; Mu C; Cai K ACS Appl Mater Interfaces; 2015 Apr; 7(13):7357-72. PubMed ID: 25765172 [TBL] [Abstract][Full Text] [Related]
7. Defect-related luminescent mesoporous silica nanoparticles employed for novel detectable nanocarrier. Ge K; Zhang C; Jia G; Ren H; Wang J; Tan A; Liang XJ; Zang A; Zhang J ACS Appl Mater Interfaces; 2015 May; 7(20):10905-14. PubMed ID: 25943277 [TBL] [Abstract][Full Text] [Related]
8. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality. Huang P; Chen Y; Lin H; Yu L; Zhang L; Wang L; Zhu Y; Shi J Biomaterials; 2017 May; 125():23-37. PubMed ID: 28226244 [TBL] [Abstract][Full Text] [Related]
9. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639 [TBL] [Abstract][Full Text] [Related]
11. Overcoming multidrug resistance with mesoporous silica nanorods as nanocarrier of doxorubicin. Li L; Huang X; Liu T; Liu H; Hao N; Chen D; Zhang Y; Li L; Tang F J Nanosci Nanotechnol; 2012 Jun; 12(6):4458-66. PubMed ID: 22905485 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766 [TBL] [Abstract][Full Text] [Related]
13. Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cells. Wang TT; Chai F; Wang CG; Li L; Liu HY; Zhang LY; Su ZM; Liao Y J Colloid Interface Sci; 2011 Jun; 358(1):109-15. PubMed ID: 21453927 [TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism. Shen J; He Q; Gao Y; Shi J; Li Y Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. Chen Y; Ai K; Liu J; Sun G; Yin Q; Lu L Biomaterials; 2015 Aug; 60():111-20. PubMed ID: 25988726 [TBL] [Abstract][Full Text] [Related]
16. Silicon-nanowire-based nanocarriers with ultrahigh drug-loading capacity for in vitro and in vivo cancer therapy. Peng F; Su Y; Wei X; Lu Y; Zhou Y; Zhong Y; Lee ST; He Y Angew Chem Int Ed Engl; 2013 Jan; 52(5):1457-61. PubMed ID: 23233367 [No Abstract] [Full Text] [Related]
17. Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia. Lu F; Popa A; Zhou S; Zhu JJ; Samia AC Chem Commun (Camb); 2013 Dec; 49(97):11436-8. PubMed ID: 24169596 [TBL] [Abstract][Full Text] [Related]
18. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells. He X; Hai L; Su J; Wang K; Wu X Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439 [TBL] [Abstract][Full Text] [Related]
19. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma. Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125 [TBL] [Abstract][Full Text] [Related]
20. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging. Yang Y; Aw J; Chen K; Liu F; Padmanabhan P; Hou Y; Cheng Z; Xing B Chem Asian J; 2011 Jun; 6(6):1381-9. PubMed ID: 21548100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]